News and Events

2018 Press Release Archive

January 14, 2019

Leap Therapeutics Announces an Investigator-Initiated Study of DKN-01 in Patients with DKK1+ Advanced Prostate Cancer.

Click here for full article.

December 14, 2018

Leap Therapeutics Presents TRX518 Data at ESMO Immuno-Oncology Congress 2018 and Updated Data from DKN-01 Study in Biliary Tract Cancer. Click here for full article.

November 9, 2018

Leap Therapeutics Reports Third Quarter 2018 Business Update and Financial Results. 

Click here for full article.

November 9, 2018

Leap Therapeutics Presents Esophagogastric Cancer Data at SITC 2018 Annual Meeting

Click here for full article.

October 21, 2018

Leap Therapeutics Presents Esophagogastric Cancer Data at ESMO 2018 Annual Congress.

Click here for full article.

October 8, 2018

Leap Therapeutics to Present Data from Study Evaluating DKN-01 in Combination with KEYTRUDA® (pembrolizumab) at the European Society of Medical Oncology 2018 Congress. Click here for full article

September 25, 2018

Leap Therapeutics to Present at Two October Conferences. Click here for full article 

August 30, 2018

Leap Therapeutics to Participate in the H.C. Wainwright 20th Annual Global Investment Conference. Click here for full article.

August 8, 2018

Leap Therapeutics Reports Second Quarter 2018 Business Update and Financial Results. Click here for full article.

July 23, 2018

Leap Therapeutics Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Combination of TRX518, Avelumab, and Chemotherapy in Advanced Solid Tumors. Click here for full article.

June 13, 2018

Leap Therapeutics to Present at the 2018 JMP Securities Life Sciences Conference. Click here for full article

May 11, 2018

Leap Therapeutics Reports First Quarter 2018 Financial Results. Click here for full article

April 16, 2018

Leap Therapeutics Presents Nonclinical and Clinical Data on DKN-01 at AACR 2018 Annual Meeting.  Click here for full article

March 27, 2018

Leap Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares. Click here for full article

March 23, 2018

Leap Therapeutics Announces Pricing of $14 Million Public Offering of Common Stock. Click here for full article

March 22, 2018

Leap Therapeutics Announces Proposed Public Offering of Common Stock. Click here for full article

March 21, 2018

Leap Therapeutics to Present at the 2018 Needham & Company 17th Annual Healthcare Conference. Click here for full article

March 14, 2018

Leap Therapeutics Provides DKN-01 Program Update and Announces Scientific Presentations at AACR Annual Meeting. Click here for full article

March 7, 2018

Leap Therapeutics to Present at 2018 Barclays Global Healthcare Conference. Click here for full article

February 23, 2018

Leap Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Announces Date of its Annual Meeting of Stockholders. Click here for full article

February 6, 2018

Leap Therapeutics to Present at the 20th Annual BIO CEO & Investor Conference. Click here for full article

January 16, 2018

Leap Therapeutics Announces First Patient Dosed with TRX518 Combination Therapy in Advanced Solid Tumors Trial. Click here for full article

Twiter Icon.png

© 2019 Leap Therapeutics, Inc.       All Rights Reserved